Coronovirus Timeline (June-November 2021)

June 2021

• June 3: “Alarm in Africa: Virus Surges, Vaccines Grind to ‘Near Halt’” (Associated Press)
• June 7: “CDC: 2-Dose Vaccines Reduce COVID-19 Infection Risk by 91%, Limit Virus Spread” (UPI)
• June 8: “U.S. Report Found It Plausible Covid-19 Leaked from Wuhan Lab” (The Wall Street Journal)
• June 9: “Covid-19 Delta Variant First Found in India Is Quickly Spreading Across Globe” (Wall Street Journal)
• June 11: “CDC Plans ‘Emergency Meeting’ on Rare Heart Inflammation Following COVID-19 Vaccines” (CBS News)
• June 14: “Texas Hospital System Can Require Employees to Get Covid-19 Vaccine Judge Rules” (The Wall Street Journal)
• June 16: “Regeneron Antibody Saves Lives in Some Hospitalized Covid Patients, Study Finds” (STAT News)
• June 18: “What Happens Now That Emergency Orders Are Lifting” (Axios)
• June 22: “South America Is Now Covid-19 Hot Spot, with Eight Times the World’s Death Rate” (The Wall Street Journal)
• June 25: “The Pandemic Led to the Biggest Drop in U.S. Life Expectancy Since WWII, Study Finds” (NPR)

July

• July 2: “Covid-19 Vaccine Passport System Gets First Test in Europe” (The Wall Street Journal)
• July 9: “Gene Hunters Turn Up New Clues to Help Explain Why Covid-19 Hits Some People So Hard” (STAT News)
• July 12: “CDC and Pfizer at Odds Over Need for COVID-19 Booster Shots” (Medscape)
• July 12: “New CDC School Guidance Calls for In-Person Classes, with Caveats” (Medscape)
• July 16: “COVID-19 Takes Toll on Catholic Clergy in Hard-Hit Countries” by Luis Andres Henao and Jessie Wardarski Associated Press,
• July 16: “Large Redemsivir Study Finds No COVID-19 Survival Benefit” (Medscape)
• July 20: “Third Covid Wave Upends Fragile South Africa, a Warning for Developing World” (The Wall Street Journal)
• July 26: “Moderna Expanding Kids Vaccine Study to Better Assess Safety” (Associated Press)
• July 28: “CDC Calls for Masks in Schools, Hard-Hit Areas Even if Vaccinated” (Medscape)
• July 30: “Covid-19 Outbreak During Olympics Leads Japan to Widen State of Emergency” (The Wall Street Journal)

August

• August 2: “US Hits 70% Vaccination Rate—A Month Late, Amid a Surge” (Associated Press)
• August 6: “Masks Are Back, Maybe for the Long Term” (The Atlantic)
• August 12: “Covid-19 Vaccine Scammers Target Authorities in Dozens of Countries Including Italy and Columbia” (The Wall Street Journal)
• August 13: “FDA Authorizes Covid-19 Boosters for Certain Immunocompromised” (The Wall Street Journal)
• August 16: “Rich Nations Dip into COVAX Supply While Poor Wait for Shots” (Associated Press)
• August 17: “Forget Beating Covid-19. Europe Is Preparing to Live with It.” (The Wall Street Journal)
• August 17: “U.S. to Advise Boosters for Most Americans 8 Months After Vaccination” (The New York Times)
• August 23: “US Regulators Give Full Approval to Pfizer COVID-19 Vaccine” (Associated Press)
• August 24: “As Delta Spread, Covid-19 Vaccine Effectiveness Against Infection Fell from 90% to 66% in One Key Study” (STAT News)
• August 27: “Moderna Complete Submission for Full FDA Approval of Covid-19 Vaccine; Pfizer Seeks Approval for Booster Dose” (CNN)

September

• September 2: “Africa Nations Set to Miss ‘Crucial’ COVID Vaccine Goal: WHO” (Medical Xpress)
• September 3: “Crowded U.S. Jails Drove Millions of COVID-19 Cases, a New Study Says” (NPR)
• September 7: “Hospitalizations for Children Sharply Increase as Delta Surge, C.D.C. Studies Find” (The New York Times)
• September 10: “Covid-19 Virus Variants Mu and Lambda Unlikely to Supplant Delta” (The Wall Street Journal)
• September 10: “FDA ‘Will Follow the Science’ to Approve COVID Vaccine for Kids Under 12” (Axios)
• September 14: “FDA Vaccine Regulators Argue Against Covid-19 Vaccine Boosters in New International Review” (STAT News)
• September 15: “As COVID-19 Vaccine Mandates Rise, Religious Exemptions Grow (Associated Press)
• September 23: “FDA Authorizes Pfizer’s Covid-19 Booster for People Over 65 or at High Risk” (STAT News)
• September 24: “CDC Leader Adds People with Risky Job to COVID Booster List” (Associated Press)
• September 28: “Pfizer Testing Oral Pill for Prevention of COVID” (Axios)

October

• October 1: “Merck Pill Intended to Treat Covid-19 Succeeds in Key Study”(The Wall Street Journal)
• October 4: “EU Regulator OKs Pfizer Vaccine Booster for 18 and Older” (Associated Press)
• October 8: “Pfizer Asks FDA to Authorize COVID Vaccine for Kids Aged 5 to 11” (Medscape)
• October 13: “NIH Study: Moderna, Pfizer Shots Are Most Effective Covid Boosters” (Politico)
• October 14: “New York Must Allow Religious Exemptions to COVID-19 Vaccine Mandate, Judge Rules” (Reuters)
• October 20: “In Secret Vaccine Contracts with Governments, Pfizer Took Hard Line in Push for Profit, Report Says” (The Washington Post)
• October 20: “FDA OKs Mixing COVID Vaccines, Backs Moderna, J&J Boosters” (Associated Press)
• October 26: “Pfizer-BioNTech Covid-19 Vaccine for Young Kids Backed by FDA Advisors” (The Wall Street Journal)
• October 27: “Merck Agrees to Let Other Drug Makers Make Its COVID Pill” (Associated Press)
• October 28: “Antidepressant Fluvoxamine Significantly Reduces Covid-19 Hospitalization” (The Wall Street Journal)

November

• November 1: “Moderna Confirms FDA Delayed Covid-19 Vaccine in Adolescents to Review Myocarditis Risk” (The Wall Street Journal)
• November 2: “Covid-19’s Global Death Toll Tops 5 Million in Under 2 Years” (Associated Press)
• November 4: “US Mandates Vaccines or Tests for Big Companies by Jan. 4” (Associated Press)
• November 4: “Molnupiravir: First Pill to Treat Covid Gets Approval in UK” (BBC)
• November 9: “U.S. Opens Borders to Vaccinated Europeans, Others, After More Than 18 Months” (The Wall Street Journal)
• November 18: “Pfizer, US Ink $5.29B Deal for Possible COVID-19 Treatment” (Associated Press)
• November 19: “OSHA Suspends Implementation of Vaccine Mandate” by (Medscape)
• November 22: “FDA Clears Pfizer, Moderna Covid Booster Shots for All Adults” (Politico)
• November 26: “WHO Identifies New Covid-19 ‘Variant of Concern’ Omicron as Strain Triggers Global Fears” (The Wall Street Journal)
• November 30: “FDA Panel Backs First-of-a-Kind COVID-19 Pill from Merck” (Associated Press)